Skip to content

Margin reduction in radiotherapy of high grade glioma

Comparison of treatment outcomes and failure pattern in high grade glioma treated with adjuvant radiotherapy based on standard protocol of RTOG versus smaller margin

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210215050367N1
Enrollment
192
Registered
2021-03-19
Start date
2021-04-04
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High grade glioma. Malignant neoplasm of brain

Interventions

Intervention 1: Intervention group: intervention group will undergo radiotherapy to the lesion (46 gray dose in 23 fractions to a margin of 1 cm to the high signal region in the , T2/ FLAIR sequences

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Newly diagnosed glioblastoma multiform patients Newly diagnosed anaplastic astrocytoma patients Newly diagnosed oligodendroglioma patients Confirmed diagnosis based on pathologic evaluation Karnofsky performance index more than 70%

Exclusion criteria

Exclusion criteria: Uncontrolled diabetes Uncontrolled high blood pressure Impossibility of surgery and tissue sampling

Design outcomes

Primary

MeasureTime frame
Progression free survival. Timepoint: At the beginning of the study and then every 3 months in the first year and every 6 months in the following years. Method of measurement: Physical exam and MRI.

Secondary

MeasureTime frame
Overall survival. Timepoint: Every 3 month in the first year and every 6 month in subsequent years. Method of measurement: Physical exam and MRI.;Pattern of failure. Timepoint: Every 3 month in the first year and every 6 month in subsequent years. Method of measurement: Physical exam and MRI.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Rabiei

Mashhad University of Medical Sciences

rabieep971@mums.ac.ir+98 51 3842 6082

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026